ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – OCGNBusiness Wire • 06/20/21
OCUGEN ALERT: Bragar Eagel & Squire, P.C. Is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 06/19/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline- OCGNPRNewsWire • 06/19/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) InvestorsBusiness Wire • 06/18/21
Notice of Lead Plaintiff Deadline for Shareholders in the Ocugen, Inc. Class Action LawsuitBusiness Wire • 06/18/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Ocugen, Inc. Shareholders and Sets a Lead Plaintiff Deadline of August 17, 2021Newsfile Corp • 06/18/21
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 06/18/21
ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 06/17/21
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 06/16/21
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation - OCGNPRNewsWire • 06/15/21
Ocugen Stock Jumps After Recruiting Jubilant HollisterStier As Manufacturing Partner For COVID-19 Vaccine CandidateBenzinga • 06/15/21
Ocugen's stock is up 14% after announcing manufacturing partner for experimental COVID-19 shotMarket Watch • 06/15/21
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN™GlobeNewsWire • 06/15/21
OCUGEN INVESTIGATION: Block & Leviton Investigates Ocugen For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmNewsfile Corp • 06/14/21